Abstract
Oral therapy for gallstones has, some say, induced more disillution than dissolution1,2; others are less pessimistic3. Few patients with gallstones fulfill the criteria for successful treatment4 and many are disappointed by the limited efficacy of dissolution therapy, or discouraged by its adverse effects, duration and cost.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dissolving hopes for gallstone dissolution (Editorial ) (1981). Lancet, 2, 905–6
Isselbacher, K J. (1981). Chenodiol for gallstones: dissolution or disillusion? (Editorial) Ann. Intern. Med., 95, 377–9
Palmer, R.H. and Carey, M.C. (1982). An optimistic view of the National Cooperative Gallstone Study. N. Engl J. Med., 306, 1171–4
Northfield, T.C. and Maudgal, D.P. (1986). Oral medical therapy. In: Bateson, M.C. (ed.), Gallstone Disease and its Management, pp. 203–27. (Lancaster: MTP Press)
Barbara, L., Sama, C., Morselli Labate A.M. et al. (1987). A Population study on the prevalence of gallstone disease: the Sirmione study. Hepatology, 7, 913–7
Fromm, H. (1986). Gallstone dissolution therapy. Current status and future prospects. Gastroenterology, 91, 1560–7
Fromm, H. (1984). Gallstone dissolution and the cholesterol-bile acid-lipoprotein axis. Propitious effect of ursodeoxycholic acid. Gastroenterology, 87, 229–33
Tint, G.S., Salen, G. and Shefer, S. (1986). Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology, 90, 1007–18
Salvioli, G., Igimi, H. and Carey, M.C. (1983). Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanism. J. Lipid Res., 24, 701–20
Corrigan, O.I., Su, C.C., Higuchi, W.I. and Hofmann, A.F. (1980). Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans. J. Pharm. Sci., 69, 869–71
von Bergmann, K., Epple-Gutsfeld, M. and Leiss, O. (1984). Differences in the effects of chenodeoxycholic and ursodeoxycholic acids in biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology, 87, 136–43
Nilsell, K., Angelin, B., Leijd, B. and Einarsson, K. (1983). Comparative effect of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in man. Evidence for different modes of action on bile acid synthesis. Gastroenterology, 85, 1248–56
Mok, H.Y.I., Bell, G.D. and Dowling, R.H. (1974). Effect of different doses of chenodeoxycholic acid on bile lipid composition and on frequency of side effects in patients with gallstones. Lancet, 2, 253–7
Thistle, J.L., Hofmann, A.F., Ott, B J. and Stephens, D.H. (1978). Chenotherapy for gallstone dissolution: I. Efficacy and safety. J. Am. Med. Assoc., 239, 1041–6
Miyai, K., Toyota, N., Jones, H.M. and Gochman, N. (1982). Protective effect of ursodeoxycholic acid against cholestatic and hepatotoxic effects of lithocholic acid (Abstr.). Hepatology, 2, 705
Krol, T., Kitamura, T., Miyai, K. and Hardison, W. (1983). Tauroursodeoxycholate reduces dictular proliferation in bile duct-ligated hamsters (Abstr.). Hepatology, 3, 881
Tanikawa, K., Kawahara, T., Kumashiro, R. et al. (1986). Effects of bile acids on the cultured hepatocyte and Kupffer cell (Abstr). Hepatology, 6, 779
Poupon, R., Chretien, Y., Poupon, R.E. et al. (1987). Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?Lancet, 1, 834–6
Podda, M., Zuin, M., Dioguardi, M.L., Festorazzi, S. and Dioguardi, N. (1982). A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation. Hepatology, 2, 334–9
Stiehl, A., Raedsch, R., Czygan, P., Gotz, R., Manner, C.H. and Walker, S. (1980). Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastoenterology, 79, 1192–8
Carey, M.C. and Ko, G. (1979). The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating ’percent cholesterol saturation’ with a correction factor for ursodeoxycholic-rich bile. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 299–308. (Lancaster: MTP Press).
Roehrkasse, R., Fromm, H., Malavolti, M., Tunuguntla, A.K. and Ceryak, S. (1986). Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool and serum lipids. Dig. Dis. Sci, 31, 1032–40
Thistle, J.L. (1987). Dissolution of gallstones using ursodeoxycholic acid with or without chenodeoxycholic acid or taurine. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 353–4. (Lancaster: MTP Press).
Czygan, P (1987). Efficacy of combined ursodeoxycholic and chenodeoxycholic acid treatment. In: Paumgartner, G., Stiehl, A. and Gerok, W. (eds.), Biological Effects of Bile Acids, pp. 343–4. (Lancaster: MTP Press).
Kawamoto, T., Horiuchi, I., Hino, F., Okahashi, M. and Kajiyama, G. (1984). Combination treatment with different doses of urso (U) and chenodeoxycholic acid (C) in patients with cholesterol gallstones (Abstr) In: Proceedings of the VIII International Bile Acid Meeting Berne, p. 183
Bateson, M.C., Bouchier, I.A.D., Trash, D.B., Maudgal, D.P. and Northfield, T.C. (1981). Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br. Med. J., 283, 645–6
Roda, E., Bazzoli, F., Labate, W.M.N, et al. (1982). Ursodeoxycholic acid vs chenodeoxycholic acid as cholesterol gallstone dissolving agents: a comparative study. Hepatology, 2, 804–10
Fromm, H., Roat, J.N., Gonzales, V., Sarva, R.J. and Farivar, S. (1983). Comparative efficacy and side effects of ursodeoxycholic acid and chenodeoxycholic acid in dissolving gallstones. Gastoenterology, 85, 1257–64
Sauerbruch, T., Delius, M., Paumgartner, G et al. (1986). Fragmentation of gallstone by extracorporeal shock waves. N. Engl. J. Med., 314, 818–22
Igimi, H. and Carey, M.C. (1980). pH-solubility relation of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar dissolution and membrane phenomena. J. Lipid Res., 21, 72–89
Schoenfield, L.J. and Lachin, J.M. (1981). The Steering Committee and the National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study .Ann. Intern. Med., 95, 257–82
Toulet, J., Rousselet, J., Viteau, J.M. et al. (1983). Dissolutions incomplete des calculs. Calcification, cholecystectomies après traitaient de la lithiase vesiculate par l’acide chenodesoxycholique. Gastroenterol, Clin. Biol, 7, 969–74
Hofmann, A.F. and Cummings, S.A. (1985). Biliary calcium secretion and its relationship to biliary calcium concentration and biliary calcium activity. In: Barbara, L., Dowling, P.H., Hofmann, A.F. and Roda, E. (eds.), Recent Advances in Bile Acid Research, pp. 87–108. (New York: Raven Press)
Bachrach, W.H. and Hofmann, A.F. (1982). Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig. Dis. Sci, 27, 833–55
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Podda, M., Zuin, M., Battezzati, P.M. (1988). Cheno- plus Ursodeoxycholic Acid. In: Northfield, T., Jazrawi, R., Zentler-Munro, P. (eds) Bile Acids in Health and Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1249-6_13
Download citation
DOI: https://doi.org/10.1007/978-94-009-1249-6_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7054-6
Online ISBN: 978-94-009-1249-6
eBook Packages: Springer Book Archive